CNAHealth
India halts Sun Pharma eye drug production at Assam plant
India has barred Sun Pharma from making eye medicines at its Assam factory until the company submits a satisfactory report addressing quality compliance lapses. The move escalates regulatory action against the country's largest drugmaker over plant operations.
This card is an AI-assisted summary of reporting published by CNA. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.